Literature DB >> 25462225

Hairpin oligonucleotides forming G-quadruplexes: new aptamers with anti-HIV activity.

Valeria Romanucci1, Maria Gaglione2, Anna Messere2, Nicoletta Potenza2, Armando Zarrelli1, Sam Noppen3, Sandra Liekens3, Jan Balzarini3, Giovanni Di Fabio4.   

Abstract

We describe the facile syntheses of new modified oligonucleotides based on d(TG3AG) that form bimolecular G-quadruplexes and possess a HEG loop as an inversion of polarity site 3'-3' or 5'-5' and aromatic residues conjugated to the 5'-end through phosphodiester bonds. The conjugated hairpin G-quadruplexes exhibited parallel orientation, high thermal stability, elevated resistance in human serum and high or moderate anti-HIV-1 activity with low cytotoxicity. Further, these molecules showed significant binding to HIV envelope glycoproteins gp120, gp41 and HSA, as revealed by SPR assays. As a result, these conjugated hairpins represent the first active anti-HIV-1 bimolecular G-quadruplexes based on the d(TG3AG) sequence.
Copyright © 2014 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Anti-HIV activity; Aptamers; Conjugated hairpin oligonucleotides; G-quadruplexes; Solid-phase synthesis

Mesh:

Substances:

Year:  2014        PMID: 25462225     DOI: 10.1016/j.ejmech.2014.10.030

Source DB:  PubMed          Journal:  Eur J Med Chem        ISSN: 0223-5234            Impact factor:   6.514


  10 in total

1.  DNA Triplex-Based Complexes Display Anti-HIV-1-Cell Fusion Activity.

Authors:  Liang Xu; Tao Zhang; Xiaoyu Xu; Huihui Chong; Wenqing Lai; Xifeng Jiang; Chao Wang; Yuxian He; Keliang Liu
Journal:  Nucleic Acid Ther       Date:  2015-08       Impact factor: 5.486

2.  Kinetic ESI-MS Studies of Potent Anti-HIV Aptamers Based on the G-Quadruplex Forming Sequence d(TGGGAG).

Authors:  Valeria Romanucci; Adrien Marchand; Oscar Mendoza; Daniele D'Alonzo; Armando Zarrelli; Valérie Gabelica; Giovanni Di Fabio
Journal:  ACS Med Chem Lett       Date:  2016-01-26       Impact factor: 4.345

Review 3.  In What Ways Do Synthetic Nucleotides and Natural Base Lesions Alter the Structural Stability of G-Quadruplex Nucleic Acids?

Authors:  Janos Sagi
Journal:  J Nucleic Acids       Date:  2017-10-18

4.  G-quadruplex prediction in E. coli genome reveals a conserved putative G-quadruplex-Hairpin-Duplex switch.

Authors:  Oktay I Kaplan; Burak Berber; Nezih Hekim; Osman Doluca
Journal:  Nucleic Acids Res       Date:  2016-09-04       Impact factor: 16.971

Review 5.  Use of Aptamers as Diagnostics Tools and Antiviral Agents for Human Viruses.

Authors:  Víctor M González; M Elena Martín; Gerónimo Fernández; Ana García-Sacristán
Journal:  Pharmaceuticals (Basel)       Date:  2016-12-16

6.  Phosphate-Linked Silibinin Dimers (PLSd): New Promising Modified Metabolites.

Authors:  Valeria Romanucci; Raffaele Gravante; Martina Cimafonte; Cinzia Di Marino; Gilles Mailhot; Marcello Brigante; Armando Zarrelli; Giovanni Di Fabio
Journal:  Molecules       Date:  2017-08-11       Impact factor: 4.411

7.  Effects of Dried Blood Spot Storage on Lipidomic Analysis.

Authors:  Cinzia Di Marino; Anna De Marco; Antonio Pisanti; Valeria Romanucci
Journal:  Molecules       Date:  2018-02-13       Impact factor: 4.411

Review 8.  Aptamers in Virology-A Consolidated Review of the Most Recent Advancements in Diagnosis and Therapy.

Authors:  Tejabhiram Yadavalli; Ipsita Volety; Deepak Shukla
Journal:  Pharmaceutics       Date:  2021-10-09       Impact factor: 6.321

9.  Abolishing HIV-1 infectivity using a polypurine tract-specific G-quadruplex-forming oligonucleotide.

Authors:  Maike Voges; Carola Schneider; Malte Sinn; Jörg S Hartig; Rudolph Reimer; Joachim Hauber; Karin Moelling
Journal:  BMC Infect Dis       Date:  2016-07-22       Impact factor: 3.090

10.  Probing the Importance of the G-Quadruplex Grooves for the Activity of the Anti-HIV-Integrase Aptamer T30923.

Authors:  Veronica Esposito; Francesca Esposito; Antonietta Pepe; Isabel Gomez Monterrey; Enzo Tramontano; Luciano Mayol; Antonella Virgilio; Aldo Galeone
Journal:  Int J Mol Sci       Date:  2020-08-06       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.